Barclays PLC Vincerx Pharma, Inc. Transaction History

Barclays PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	SELL	$0.62 - $1.18 $1,570 - $2,988	-2,533 Reduced 99.1%	23 $0
Q4 2022 Feb 13, 2023	SELL	$0.64 - $1.32 $3,080 - $6,354	-4,814 Reduced 65.32%	2,556 $3,000
Q2 2022 Aug 12, 2022	SELL	$0.0 - $0.0 $0 - $0	-3,472 Reduced 32.02%	7,370 $10,000
Q1 2022 May 16, 2022	BUY	$0.0 - $0.0 $0 - $0	10,842 New	10,842 $43,000

11M

Ticker VINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,189,800
Market Cap $6.57M
Description
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.